Tandem mass spectrometric approaches for the analysis of alkylguanines in human urine
✍ Scribed by J. R. Cushnir; S. Naylor; J. H. Lamb; P. B. Farmer
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 621 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1076-5174
No coin nor oath required. For personal study only.
✦ Synopsis
Human exposure to carcinogenic alkylating agents can lead to the formation of covalently bound adducts in DNA, some of which are excreted in urine as alkylated purines following DNA degradation and repair. Tandem mass spectrometric methods have been developed for the qualitative and quantitative determination of such alkylpurines in human urine. Short-chain alkyl-and hydroxyalkylguanines have been synthesized with the substituents at the N-7-, 06-and p-positions of guanine. Examination of the product ion scans of their molecular ions (electron impact (EI) ionization) revealed that the ion at m/z 151, [guanine]', was common to all of the alkylguanines studied, with the exception of the methylated analogues. Precursor ion scans of this ion on partially purified human urine extracts showed the presence of several ions (e.g. m/z 179, 195) which were consistent with molecular ions for alkylguanines. The presence of these and other constituents was confirmed by product ion spectra of molecular ions (EI and fast atom bombardment), and by high-performance liquid chromatographic separation prior to tandem mass spectrometry (MS/MS). Evidence was obtained for the presence of N-7-methyl-, p-methyl-, p-dimethyl-, Methyl-and N-7-(2-hydroxyethyl)guanine. Quantitative methods were established for these five alkyl guanines using gas chromatography mass spectrometry (GC/MS) and GC/MS/MS. Deuterated internal standards were synthesized and added to the urine prior to extraction of alkylpurines by SepPak cartridge chromatography. The products were converted into their tert-butyldimethylsilyl derivatives and analysed by selected ion monitoring (SIM) of [ M -571 + or by multiple reaction monitoring (MRM) of the fragmentation M+' + [ M -571 +. The MRM method yielded values for N-7-methylguanine of 2.57 f S.D. 132 mg day-' (n = 6), M-methylguanine of 0.31 f 0.10 mg day-' (n = 10) and p-dimethylguanine of 0.21 f 0.23 mg day-' (n = 10). M-Ethyl-and N-742-hydroxyethy1)guanine could only be detected by SIM at levels of -0.5 and 2 p g day-', respectively. The MRM analyses, although inherently less sensitive than the SIM .
. -.
analyses, exhibit greater selectivity and consequently fewer contaminant ions.
📜 SIMILAR VOLUMES
## Abstract A specific LC‐MS method was developed that allowed simultaneous determination of puerarin (PU) and its major metabolite, daidzein (DA), in human urine samples. PU and DA were separated on a packed capillary ODS column with on column concentration. Identification and quantification of th
## Abstract Electrospray ionization (ESI) mass spectra of 19 common β~2~‐agonists were investigated in terms of fragmentation pattern and dissociation behavior of the analytes, proving the origin of fragment ions and indicating mechanisms of charge‐driven and charge‐remote fragmentation. Based on t
A method for the confirmatory analysis of clenbuterol in human and bovine urine was developed. After a double washing of the acidified sample with fert-butyl methyl ether (only for bovine urine), and a solid-phase extraction with Bond-Elut Certify@ columns, derivatization was performed with trimethy
## Abstract A specific and rapid liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method was developed and validated for NNAL, a metabolite of the tobacco‐specific nitrosamine metabolite NNK. The metabolite was detected in smokers' urine with a limit of quantitation (LOQ) of 20 pg ml^−1^